MicroRNA-29: a potential therapeutic target for systemic sclerosis. - Wikidata - awgldk - TriplyDB

MicroRNA-29: a potential therapeutic target for systemic sclerosis.

MicroRNA-29: a potential therapeutic target for systemic sclerosis.

http://www.wikidata.org/entity/Q38026072

about

MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic Sclerosis Role of the microRNA-29 family in fibrotic skin diseases.MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis Role of microRNAs in gastrointestinal smooth muscle fibrosis and dysfunction: novel molecular perspectives on the pathophysiology and therapeutic targeting.Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.The role of microRNAs in skin fibrosis.MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma.The role of microRNAs in autoimmune diseases with skin involvement.Genetic and epigenetic abnormalities in systemic sclerosis.MicroRNA-210 and its theranostic potential.MicroRNA-29: A Crucial Player in Fibrotic Disease.Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis.

P2860

Q26781257-C14E906D-0CD1-4CA0-9241-6C7CEEFB7D23 Q33742115-82EB5CB1-3FF7-46A7-8125-F72D91D03B44 Q34790405-7BF245F6-DBD4-4828-81E6-139FCB719E82 Q36775830-EDA1E707-2013-4C51-9C71-99BB2509268F Q36965488-E0CE398F-50B4-4AFC-9306-F11F17632E5E Q37224668-2FD1D2A3-F962-47E0-A573-D732837CD84B Q37691772-B38DF616-860E-47EE-A08D-CA414DE1CC47 Q38139865-5311EDF8-686D-4E22-A927-3EF452F62256 Q38272151-560523FC-725E-4A44-9029-54297FF09A06 Q38701980-06597ACD-4BF4-4F08-A67E-B2F8B096ED3E Q38881607-1FFF6EC0-9445-4F48-9151-385C93F25AF5 Q39107249-C1077797-2297-460D-B6EB-307F6B822972 Q39129418-C8B0D22E-3CCF-4AC7-BFB4-19609FEDD963

P2860

MicroRNA-29: a potential therapeutic target for systemic sclerosis.

http://www.wikidata.org/entity/Q38026072

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

MicroRNA-29: a potential therapeutic target for systemic sclerosis.

@en

type

label

MicroRNA-29: a potential therapeutic target for systemic sclerosis.

@en

prefLabel

MicroRNA-29: a potential therapeutic target for systemic sclerosis.

@en

P1433

Q38026072-911E2863-483E-420D-B565-1567507B4358

P1476

Q38026072-B7C866EA-3130-444C-A223-BFEE604D896E

P2093

Q38026072-00622D61-A592-4155-AAAD-3C61B481D218

Q38026072-2D85F8FF-1891-408A-B8CE-184DAA8E2055

Q38026072-328E4DE9-3C19-4DC5-9B1A-CBE21805830A

Q38026072-41BFA2F0-EEA8-42DD-86DB-F65BFDA2F931

Q38026072-48F308F8-7654-468D-900E-F3D15545824E

Q38026072-82E6C6CA-D02A-44B6-B639-1E8AE28524CE

Q38026072-8428ABBC-EB92-4164-B629-7B24FA137CF6

Q38026072-88C81056-1326-4928-AE20-E7A5FB138DF1

Q38026072-8C4CFE3E-BD56-4C31-BF19-4C6E9EF52913

Q38026072-8DB19704-DC3B-4F25-B956-E1166CDD2433

P2860

Q38026072-1171E57B-DC47-42CE-BA48-E738443A8800

Q38026072-11F59445-BBB1-4840-94F8-710F8FB2DFD7

Q38026072-163AB6EC-A19A-48CA-AE22-4C38617973B9

Q38026072-1D86CB1C-2CC7-4E0A-AFC4-FD5EB505C9FE

Q38026072-25111D16-5B4F-4433-848C-B75961A01AB9

Q38026072-27110399-5C3F-4CA5-9D3D-30748F8C9667

Q38026072-2CB26279-E783-4709-9597-B4C6BF276ACA

Q38026072-4172F8DD-BBA7-4BDB-82C4-D12528DC24A8

Q38026072-44398A01-9C6D-4354-B378-2FF3B85C2DC8

Q38026072-4E963F9D-0A65-4DDE-AB3F-558A7D1EBE42

P304

Q38026072-5FF815F5-7FA2-4419-A92B-1B1DAB72111E

P31

Q38026072-F355B268-A8B9-479D-B042-AE1D6154801C

P356

Q38026072-CC56520C-F109-481C-B847-18CB36B8651E

P407

Q38026072-6E4BDA08-C9E9-4F5A-B2CA-C98189AB3780

P433

Q38026072-9FB0A67E-685F-4897-813C-3FB0418499CC

P478

Q38026072-EC205C30-B749-47A0-9DEB-CD747E9D9AE7

P577

Q38026072-CEC7F11E-87A4-4E88-B82D-C6B36621C831

P698

Q38026072-9D8EB85E-0122-4BF8-B38B-0730E84AF8F5

P921

Q38026072-BF6370B6-36E5-4680-8082-520B808A2E0B

P356

14728222.2012.708339

P1433

Expert Opinion on Therapeutic Targets

P1476

MicroRNA-29: a potential therapeutic target for systemic sclerosis.

@en

P2093

Bao-Zhu Li

http://www.w3.org/2001/XMLSchema#string

Bin Mei

http://www.w3.org/2001/XMLSchema#string

Bing Chen

http://www.w3.org/2001/XMLSchema#string

Bing-Xiang Wang

http://www.w3.org/2001/XMLSchema#string

Guo-Jun Yang

http://www.w3.org/2001/XMLSchema#string

Hua Yao

http://www.w3.org/2001/XMLSchema#string

Jin-Hui Tao

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Qian He

http://www.w3.org/2001/XMLSchema#string

Qiong Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The Drosha-DGCR8 complex in primary microRNA processing

MicroRNAs: target recognition and regulatory functions

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Suppression of type I collagen production by microRNA-29b in cultured human stellate cells

Regulation of mRNA translation and stability by microRNAs

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

Systemic sclerosis.

MicroRNAs and the regulation of fibrosis.

MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma.

Coordinated regulation of extracellular matrix synthesis by the microRNA-29 family in the trabecular meshwork

P304

875-879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2012.708339

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22793265

http://www.w3.org/2001/XMLSchema#string

P921